Organ-specific metastasis is the primary cause of cancer patient death. The distant
metastasis of tumor cells to specific organs depends on both the intrinsic characteristics of …

Rare cells play essential roles in the initiation and progression of diseases and therefore
their analysis is of great interest. The micro-magnetofluidic system is one of the emerging …

Therapeutic resistance in cancer significantly contributes to mortality, with many patients
eventually experiencing recurrence after initial treatment responses. Recent studies have …

Although metastasis is the leading cause of cancer deaths, it is quite rare at the cellular
level. Only a rare subset of cancer cells (~ 1 in 1.5 billion) can complete the entire metastatic …

Pancreatic ductal adenocarcinoma (PDAC) has a five-year survival rate of less than 10%
due to its late diagnosis, rapid metastasis, and chemotherapeutic resistance. For a small …

Background Post-acute COVID-19 syndrome (PACS) is linked to severe organ damage. The
identification and stratification of at-risk SARS-CoV-2 infected individuals is vital to providing …

The evolutionary dynamics of cancer, characterized by its profound heterogeneity, demand
sophisticated tools for a holistic understanding. This review delves into tumor phylogenetics …

Background Cancer becomes lethal as it spreads from the primary site to the rest of the
body. Circulating tumor cells (CTCs) are biomarkers of disease progression and have been …

Abstract Background/Objectives: Up to 30% of patients with breast cancers will develop
brain or leptomeningeal metastases, and this risk is especially high with HER2-positive …

Background Lung cancer screening with low‐dose computed tomography (CT) scans
(LDCT) has reduced mortality for patients with high‐risk smoking histories, but it has …